Filing Flows › Inogen (INGN) › Q1 2026 › vs Q1 2025
Inogen (INGN) Q1 2026 vs Q1 2025 (year over year)
Inogen's revenue rose $2.8M (+3%) from $82.3M in Q1 2025 to $85.1M in Q1 2026.
Inogen, Q1 2026: revenue $85.1M (+3% year over year), operating margin -11.0%, net loss $8.3M, operating cash flow −$6.7M. The chart draws each line against Q1 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q1 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $85.1M | $82.3M | $2.8M | +3% |
| Other income, net | $838K | $1.4M | −$547K | -39% |
| Income tax benefit | $174K | $97K | $77K | +79% |
| Net loss | $8.3M | $6.2M | $2.1M | +35% |
| Costs & expenses | $94.4M | $89.9M | $4.5M | +5% |
| Operating costs | $94.4M | $89.9M | $4.5M | +5% |
| Cost of revenue | $47.2M | $45.9M | $1.3M | +3% |
| Research & development | $5.1M | $4.0M | $1.1M | +26% |
| Sales & marketing | $24.6M | $23.8M | $846K | +4% |
| General & admin | $17.5M | $16.2M | $1.3M | +8% |
| Operating cash sources | $13.5M | $24.1M | −$10.6M | -44% |
| Depreciation & amortization | $4.9M | $5.2M | −$285K | -5% |
| Share-based compensation | $1.9M | $2.1M | −$197K | -9% |
| Cash used in operations | $6.7M | $16.8M | −$10.1M | -60% |
| Net loss absorbed | $8.3M | $6.2M | $2.1M | +35% |
| Working capital & other | $5.2M | $18.0M | −$12.7M | -71% |
Questions
How much did Inogen's revenue grow year over year in Q1 2026?
Inogen's revenue rose $2.8M (+3%) from $82.3M in Q1 2025 to $85.1M in Q1 2026.